JPS60222476A - Tocopherol ferulate - Google Patents

Tocopherol ferulate

Info

Publication number
JPS60222476A
JPS60222476A JP7706084A JP7706084A JPS60222476A JP S60222476 A JPS60222476 A JP S60222476A JP 7706084 A JP7706084 A JP 7706084A JP 7706084 A JP7706084 A JP 7706084A JP S60222476 A JPS60222476 A JP S60222476A
Authority
JP
Japan
Prior art keywords
vef
tocopherol
ferulic acid
vitamin
fats
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7706084A
Other languages
Japanese (ja)
Other versions
JPS6152151B2 (en
Inventor
Yoshihiro Chikamatsu
義博 近松
Yutaka Ando
裕 安藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ichimaru Pharcos Co Ltd
Original Assignee
Ichimaru Pharcos Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ichimaru Pharcos Co Ltd filed Critical Ichimaru Pharcos Co Ltd
Priority to JP7706084A priority Critical patent/JPS60222476A/en
Publication of JPS60222476A publication Critical patent/JPS60222476A/en
Publication of JPS6152151B2 publication Critical patent/JPS6152151B2/ja
Granted legal-status Critical Current

Links

Abstract

NEW MATERIAL:The ester of tocopherol with ferulic acid represented by the formula. USE:A drug for a preventing or curing adults diseases or promoting the secretion of bile. PREPARATION:For example, the reaction of dl-alpha-tocopherol (Vitamin E) with ferulic acid give the compound of the formula.

Description

【発明の詳細な説明】 本発明は、ビタミンE(トコフェロール)ニフエルラ酸
を反応させて得られる、新規ビタミンE・フェルラ酸エ
ステル(以下、便宜上、VEFと呼ぶ)に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel vitamin E ferulic acid ester (hereinafter referred to as VEF for convenience) obtained by reacting vitamin E (tocopherol) with niferulic acid.

VEFは、油脂類(脂質)に対する抗酸化作用を有し、
とくに加温下の油脂類に対する抗酸化作用に優れた効果
を示すものである。
VEF has an antioxidant effect on oils and fats (lipids),
In particular, it shows excellent antioxidant effects on oils and fats under heating.

以下にVEFについて、実施例及びその実験結果゛を示
し、具体的に述べる。
Examples and experimental results of VEF will be shown and specifically described below.

〔実施例−1〕 製造法: dl−σ−トコフェロール75g、フェルラ酸48 f
を、ジメチルホルムアミド300 、、l!、ピリジン
150、.1の混液に溶解し、還流冷却器を付けた撹拌
機中に入れ、撹拌下でジケテン30 、neを除々に加
える。反応系は、反応熱により上昇するも、更に水浴を
用いて70〜75C0の温度に保ち、2時間反応させる
。次いで反応物を冷却してから、5eの水中に注油し、
ベンゼン2,5aを加えて、ベンゼン層部に移行した、
反応物(エステル)を抽出する。
[Example-1] Production method: 75 g of dl-σ-tocopherol, 48 f of ferulic acid
, dimethylformamide 300,,l! , pyridine 150, . Dissolve the mixture in a mixture of 1 and 1, place the mixture in a stirrer equipped with a reflux condenser, and gradually add 30 ne of diketene while stirring. Although the temperature of the reaction system increases due to the heat of reaction, the temperature is maintained at 70 to 75 C0 using a water bath, and the reaction is continued for 2 hours. The reactants were then cooled and then lubricated into 5e water,
Benzene 2,5a was added and transferred to the benzene layer,
Extract the reactant (ester).

抽出には、ベンゼン層部を、IN塩酸2J?、IN炭酸
水素ナトリウム21で洗浄後、数回適量の水で洗浄した
後、窒素気流下で真空濃縮して、VEFを得る。
For extraction, the benzene layer was extracted with 2J of IN hydrochloric acid. , IN sodium bicarbonate 21, washed several times with an appropriate amount of water, and concentrated in vacuo under a nitrogen stream to obtain VEF.

〔実施例−2〕 製造法: フェルラ酸209を、300−eの三角フラスコにとり
、ジメチルホルムアミド10−1を加えて、溶解させた
後、塩化チオニル50 fを加えて、撹拌下に1時間還
流させた後、塩化チオニルを減圧で除き、ベンゼン適量
で洗浄し、濾過して、沈澱物を乾燥状態で得る。ここに
得られたフェルラ酸クロライド塩酸塩を、1eのコルベ
ンにとり、ピリジン40 、、l、ベンゼン200− 
lを加えて、これに、dl−α−トコフェロール40 
fを、ベンゼン100、rLlに溶解したものを加えて
、2時間還流する。還流後は冷却して濾過を行い、濾液
をとり、窒素気流下で真空濃縮して、VEFを得る。
[Example-2] Production method: Ferulic acid 209 was placed in a 300-e Erlenmeyer flask, dimethylformamide 10-1 was added and dissolved, then thionyl chloride 50 f was added and refluxed for 1 hour while stirring. After this, thionyl chloride is removed under reduced pressure, washed with an appropriate amount of benzene, and filtered to obtain a precipitate in a dry state. The ferulic acid chloride hydrochloride obtained here was taken in a colben (1e), and pyridine 40, l, benzene 200 -
To this, add dl-α-tocopherol 40
A solution of f in benzene 100 rLl is added, and the mixture is refluxed for 2 hours. After refluxing, the mixture is cooled and filtered, and the filtrate is collected and concentrated in vacuo under a nitrogen stream to obtain VEF.

〔実験結果〕〔Experimental result〕

上記した実施例で示す方法により得られたVEFは、第
1図に示すU■吸収を有し、赤外吸収スペクトルは、第
2図のごとくの特徴を有している。
The VEF obtained by the method shown in the above-mentioned Examples has the U-absorption shown in FIG. 1, and the infrared absorption spectrum has the characteristics as shown in FIG. 2.

VEFの作用(効果)は、その抗酸化作用にあり、これ
を例えばリノール酸に対する効果についてみると、第1
表に示すごとくとなり、VEFは、dl−α−トコフェ
ロールと同様にして、リノール酸の過酸化物価の上昇を
抑制し、とくに45C0の恒温槽中においては、VEF
が非常に優れた抗酸化作用を示すことがわかった。
The action (effect) of VEF lies in its antioxidant action, and when looking at its effect on linoleic acid, for example, the first
As shown in the table, VEF suppresses the increase in the peroxide value of linoleic acid in the same way as dl-α-tocopherol, and especially in a 45C0 constant temperature bath, VEF
was found to exhibit excellent antioxidant effects.

(表−1) VEFの過酸化物価(抗酸化作用)上表(
11)における条件は、透明なガラス容器中に検体を入
れ、所定の場所に放置して、その経時的な変化について
、過酸化物価値を測定した。
(Table-1) Peroxide value (antioxidant effect) of VEF in the above table (
Conditions 11) were as follows: A sample was placed in a transparent glass container, left in a predetermined location, and the peroxide value was measured based on changes over time.

〔安全性〕〔safety〕

VEFの急性毒性試験は、体重30g前後の雌性dd系
マウスを用い、4000mf/hの経口投与と8000
 mf / nの経口投与の二群(一群3匹)で実施し
たが、死亡例、中毒症状の発現は認められなかった。し
たがって、VEFの急性LD50値は、8000 、、
’l /幻 以上と推定された。
The acute toxicity test of VEF was conducted using female DD mice weighing around 30 g, with oral administration of 4000 mf/h and 8000 mf/h.
Two groups (3 animals per group) of oral administration of mf/n were conducted, but no deaths or symptoms of toxicity were observed. Therefore, the acute LD50 value of VEF is 8000,
It was estimated to be more than 'l/phantom.

〔用途又は応用(利用)分野〕[Application or application (utilization) field]

VEFは、各種油脂類及び油脂類を含有する食品類、化
粧品、医薬品、飼料等の抗酸化剤として用いることが可
能であると共に、ビタミンEの有する効果が期待される
。つまり、スタート物質として用いられるビタミンEは
、抗不妊ビタミンの一つとして発見されて以来、その後
の研究により、生体内の脂質の過酸化物の生成を抑制し
、生体膜の安定化に働き、生殖腺機能を賦活させ、さら
に末梢血管の拡張作用、サクシ=・・クソイダーゼなど
の酵素に作用して、物質代謝に好影響を与え、これによ
って、動脈硬化、糖尿病、更年期障害など、成人病の予
防と治療に繁用されるに至っている。一方、フェルラ酸
は、植物中に含まれる一成分として、とくに穀類中に含
有している。
VEF can be used as an antioxidant in various oils and fats and foods containing oils and fats, cosmetics, medicines, feeds, etc., and is also expected to have the effects of vitamin E. In other words, since vitamin E, which is used as a starting substance, was discovered as an anti-infertility vitamin, subsequent research has shown that it suppresses the production of lipid peroxides in living organisms and works to stabilize biological membranes. Activates gonadal function, expands peripheral blood vessels, acts on enzymes such as succinidase, and has a positive effect on substance metabolism, thereby preventing adult diseases such as arteriosclerosis, diabetes, and menopausal symptoms. It has come to be frequently used for treatment. On the other hand, ferulic acid is a component contained in plants, particularly in grains.

フェルラ酸は、抗酸化作用があると共に、その経口投与
は、これによって胆汁分泌の促進作用が知られている。
Ferulic acid has an antioxidant effect, and oral administration thereof is known to promote bile secretion.

したがって、VEFの応用分野は、体内に吸収されたの
ち、ビタミンEとフェルラ酸の有する両件用を発揮し、
とくに胆汁分泌を促進して、胆石や肝障害を防ぐことが
期待される。又、化粧品類や食品類、飼料等への配合は
、その加工(製剤化)上、加熱条件がともなうが、この
ような場合には、処方中の油脂類は、その製品化された
後に、急速に過酸化物価が高まることが多い。とくに夏
場の高温、多湿条件下では、製品に対する影響も強くな
り、その結果は油脂特有の酸敗臭も強く現われるが、V
EFを添加した場合では、これらの影響を防ぐことが出
来る。
Therefore, the application field of VEF is to exert the dual functions of vitamin E and ferulic acid after being absorbed into the body.
In particular, it is expected to promote bile secretion and prevent gallstones and liver damage. In addition, when blending into cosmetics, foods, feeds, etc., heating conditions are required during processing (formulation), but in such cases, the oils and fats in the formulation may be Peroxide values often increase rapidly. Especially under high temperature and high humidity conditions in the summer, the effect on the product becomes stronger, and as a result, the rancid odor characteristic of oils and fats appears strongly, but V
When EF is added, these effects can be prevented.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は、V E、Fの有する紫外線吸収スペクトルテ
アル。Aftd6−σ−トコフェロール、Bは、VEF
である。 第2図は、VEFの赤外線吸収スペクトルである。 特許出願人 II/II 、、。 s2図
Figure 1 shows the ultraviolet absorption spectra of VE and F. Aftd6-σ-tocopherol, B is VEF
It is. FIG. 2 is an infrared absorption spectrum of VEF. Patent Applicant II/II. s2 diagram

Claims (1)

【特許請求の範囲】[Claims] (1)一般式が〔1〕で示される、トコフェロールとフ
ェルラ酸とのエステル。 しi3
(1) An ester of tocopherol and ferulic acid whose general formula is represented by [1]. Shii3
JP7706084A 1984-04-17 1984-04-17 Tocopherol ferulate Granted JPS60222476A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7706084A JPS60222476A (en) 1984-04-17 1984-04-17 Tocopherol ferulate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7706084A JPS60222476A (en) 1984-04-17 1984-04-17 Tocopherol ferulate

Publications (2)

Publication Number Publication Date
JPS60222476A true JPS60222476A (en) 1985-11-07
JPS6152151B2 JPS6152151B2 (en) 1986-11-12

Family

ID=13623246

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7706084A Granted JPS60222476A (en) 1984-04-17 1984-04-17 Tocopherol ferulate

Country Status (1)

Country Link
JP (1) JPS60222476A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260598A2 (en) * 1986-09-15 1988-03-23 F. Hoffmann-La Roche Ag Light-protecting agent with an amount of unsaturated esters
JP2002284625A (en) * 2001-03-23 2002-10-03 Nippon Hypox Lab Inc Cosmetics

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260598A2 (en) * 1986-09-15 1988-03-23 F. Hoffmann-La Roche Ag Light-protecting agent with an amount of unsaturated esters
JP2002284625A (en) * 2001-03-23 2002-10-03 Nippon Hypox Lab Inc Cosmetics

Also Published As

Publication number Publication date
JPS6152151B2 (en) 1986-11-12

Similar Documents

Publication Publication Date Title
US3262850A (en) Methods for reducing cholesterol in the blood
CN108653276B (en) Application of 3-aryl coumarin compound
CN111643452A (en) Oxyresveratrol nanoemulsion as well as preparation method and application thereof
US4617317A (en) Method of treating ulcerative colitis
FR2643073A1 (en) PROCESS FOR THE PREPARATION OF PURIFIED FLAVAN-3-OL POLYPHENOLIC EXTRACTS AND EXTRACTS OBTAINED
JP2009029772A (en) Enzyme-treated royal jelly, and antioxidant, moisturizer, skin fibroblast proliferation promoter, hypotensive, fatigue-relieving agent and calcium absorption promoter, each containing the same
JPS60222476A (en) Tocopherol ferulate
JPH10140154A (en) Antioxidant
JP3977889B2 (en) Drugs containing buckwheat husk extract as an active ingredient
JPS6089488A (en) Manufacture of novel amino acid derivative
JP2742982B2 (en) Active oxygen scavenger
US4046765A (en) Dihydroquinoline derivatives of antioxidant activity and a process for the preparation thereof
JPH10287582A (en) Suppressant for liberation of histamine comprising bark extract
JPS5940179B2 (en) Antioxidant
JP2018065769A (en) Anti-saccharification composition
JP5985386B2 (en) FLAVANONE COMPOUND, ANTIOXIDANT CONTAINING THE SAME, AND METHOD FOR PRODUCING THE SAME
JP2001510439A (en) Polyester cyclic compound, complex thereof and conjugate thereof
JP3512552B2 (en) Arteriosclerosis inhibitor and food or medicine containing it
JPS6328070B2 (en)
US2912360A (en) Process for obtaining intrinsic factor
SU740250A1 (en) Method of preparing naringin
US1162908A (en) Art of obtaining vitamins.
JPS5927825A (en) Drug for external use
US4677118A (en) Composition and method for treatment of copper deficiency
JPH0723391B2 (en) Ascorbic acid-geraniin conjugate